Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

93.55 +1.46 (+1.59%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,703,026
Open 92.45
Bid (Size) 93.52 (3)
Ask (Size) 93.65 (1)
Prev. Close 92.09
Today's Range 92.45 - 94.08
52wk Range 15.32 - 94.56
Shares Outstanding 2,531,374,696
Dividend Yield 2.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Quality Dividend Stocks to Buy on the Dip
While the current market environment is full of uncertainty, these dividend stocks to buy offer a hedge against the rampant inflation rates. 
Via InvestorPlace
7 Retirement Stocks to Buy for Any Market Conditions
Though investors’ nerves are shaken due to the volatility, these proven ideas should withstand the pressure. 
Via InvestorPlace

Performance

YTD
+21.70%
+21.70%
1 Month
+8.20%
+8.20%
3 Month
+22.50%
+22.50%
6 Month
+15.92%
+15.92%
1 Year
+17.44%
+17.44%

More News

Read More
CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting
Via Benzinga
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection
From Merck & Co., Inc.
Via Business Wire
Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer
Via Benzinga
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023
Via Benzinga
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
Via Investor's Business Daily
7 Dividend Stocks to Boost Your Retirement Savings
Via InvestorPlace
Merck & Co Whale Trades For May 18
Via Benzinga
Jazz Pharmaceuticals Stock Sees Rising Price Performance With Jump To 81 RS Rating
Via Investor's Business Daily
CNBC's Final Trades: Low Volatility ETF, Kinder Morgan And This Pharma Major
Via Benzinga
4 Stocks Moved By Traders On 'Fast Money: Halftime Report'
Via Benzinga
7 Retirement Stocks for Steady Long-Term Income Growth
Via InvestorPlace
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Via Talk Markets
Stocks Are Undervalued
Via Talk Markets
7 Profitable Places to Hide Your Money During a Bear Market
Via InvestorPlace
CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks
Via Benzinga
15 Stocks Moved By Traders on 'Fast Money: Halftime Report'
Via Benzinga
Analyzing Merck & Co's Short Interest
Via Benzinga
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)
From Merck & Co., Inc.
Via Business Wire
Dow Giants Chevron, Merck Lead Five Stocks Showing Strength In A Bad Market
Via Investor's Business Daily
7 Defensive Dividend Healthcare Stocks to Buy Now
Via InvestorPlace
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
Via Benzinga
Organon Easily Beats First-Quarter Expectations Despite Nexplanon Slip-Up
Via Investor's Business Daily
CNBC's Final Trades: Honeywell International, Merck And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.